Skip to main content
DreamCIS INC. logo

DreamCIS INC. — Investor Relations & Filings

Ticker · 223250 ISIN · KR7223250002 KO Professional, scientific and technical activities
Open in API
Filings indexed 198 across all filing types
Latest filing 2025-01-02 Regulatory Filings
Country KR South Korea
Listing KO 223250

About DreamCIS INC.

https://dreamcis.com/

DreamCIS INC. is a contract research organization (CRO) that provides comprehensive clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company's offerings cover the full lifecycle of clinical development, including project management, biostatistics, and data management for clinical trials and post-marketing surveillance. DreamCIS specializes in a wide range of therapeutic areas, with extensive experience in oncology, cardiovascular diseases, endocrinology, and rare diseases. In addition to full-service clinical development, the company also provides standalone services, dedicated support for medical device trials, and strategic consulting to guide clients through complex regulatory and development processes.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 97% confidence The document is a formal regulatory filing from a Korean company (DreamCIS) announcing a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty nature, duration, and payment terms. Since this is a specific regulatory disclosure of a material business event (a major contract) that does not fit into categories like financial reports, dividends, or management changes, it falls under the 'Regulatory Filings' category.
2025-01-02 Korean
[기재정정]반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (반기보고서) for DreamCIS, which is a comprehensive financial report covering the period from January 1, 2024, to June 30, 2024. It includes detailed corporate information, business descriptions, and financial data. Although it is labeled as a 'correction' (정정) filing, it constitutes the full interim report itself, not just an announcement of one. Therefore, it falls under the category of Interim / Quarterly Report. H1 2024
2024-12-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a formal notice regarding the setting of a record date and the closure of the shareholder register for the purpose of holding an upcoming Annual General Meeting (AGM). This type of regulatory disclosure is a standard corporate announcement regarding shareholder rights and meeting preparation, which falls under the general regulatory filing category as it does not fit into specific categories like dividend announcements or proxy solicitations.
2024-12-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the share acquisition (insider trading) by a director (Jeounghee Yoo) of DreamCIS. This falls under the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2024-12-16 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'DreamCIS' (주식회사 드림씨아이에스) covering the period from January 1, 2024, to September 30, 2024. It contains detailed corporate information, business descriptions, capital changes, and financial management details, which is characteristic of a comprehensive quarterly financial report. It is not a mere announcement or certification, but the full report itself. 9M 2024
2024-11-14 Korean
[기재정정]유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (DreamCIS) regarding a 'Capital Increase Decision' (유상증자결정) for its subsidiary (Meditip). It details the issuance of new shares, the purpose of the capital raise (acquisition of business and securities), and the list of third-party allottees. This falls under the category of share issuance and capital changes.
2024-09-24 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.